AptaTargets
A clinical stage biopharmaceutical company focused in developing therapeutic applications based on aptamer technology.
- biotechnology
- horizon europe
- dt and ls
- woman founder
- spinout
- biotech and pharma
- eit ecosystem
- genetics and genomics
- neurology
- eit health
- eit supernovas
- eicfund
- headstart (eit health)
- immune system
- microbiology
- european health catapult (eit health)
- rna
- headstart 2018 (eit health)
- bridgehead europe (eit health)
- european health catapult 2018 (eit health)
- bridgehead europe 2019 (eit health)
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 204 % | 57 % | 2 % | (14 %) | 12 % | 20 % | 8 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 2 % | 13 % | 5 % | 13 % | 15 % | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | 6 % | (2 %) | 2 % | 1 % | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.